INSPIRING EXAMPLES from the site LIBRARIES for most common cancer types
What and Why
2024 clinical study shows common antihistamine triples progression free periods following immunotherapy for lung cancers . Antihistamines amplify the actions of oncology drugs including immunotherapy
Balance and maintain your natural IMMUNE SYSTEM to help slow progression during and after treatment
Canadian clinical study from 2018 in colorectal cancer shows about half the risk for disease progresion with regular tree nut consumption. Which they assign to improved vascular health, a key way to reduce metastatic activity
Get more IMPACT from your oncology treatments. Find evidence here that can often help improve outcomes
In breast cancer 2019 meta analysis reports half the risk of progression for sustained use of danshen. Disruption of so called CCL2/STAT3 axis enhances natural immune reactions against tumor cells
Improve CRUCIAL markers of your vascular and metabolic health to reduce METASTATIC activity